Aveanna Healthcare (AVAH) Stock
US home health provider for children and adults. Here's the price, business snapshot, and what's worth knowing about Aveanna Healthcare in August 2026.
Aveanna Healthcare Holdings Inc (AVAH) is a US-based provider of home health, paediatric homecare and related speciality services. The company operates through a network of clinician-led home visits and care coordination, serving children and adults who need long-term nursing, therapy or in-home support. Key revenue drivers include demand for home-based care as systems shift away from institutional settings, demographic trends such as an ageing population, and specialised paediatric programmes that can command higher margins. Investors should note the company’s sensitivity to reimbursement rates, regulatory oversight, staffing costs and integration risks from acquisitions — all factors that can pressure margins and cash flow. With a market capitalisation around $2.14bn, Aveanna sits in the small-to-mid cap space where growth potential exists but volatility can be greater. This summary is for educational purposes only; not financial advice. Always assess suitability for your own circumstances and remember that values can rise and fall.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Avanna Healthcare's stock with a target price of $7.05, indicating potential growth.
Financial Health
Aveanna Healthcare is generating steady revenue and cash flow, but profit margins are moderate.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why You’ll Want to Watch This Stock
Home-care demand
Shift from hospitals to home care and an ageing population support long-term demand, though growth can be uneven and sensitive to policy changes.
Specialised paediatric services
Aveanna’s focus on paediatric and complex care niches can yield higher-value contracts, yet these services require skilled staff and strict regulatory compliance.
Operational focus
Efficiency, workforce management and successful integration of acquisitions are critical to margins, and missteps can weigh on profitability.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
